CFTR p.Leu967Ser
Variant summary
The NM_000492.4(CFTR):c.2900T>C (p.Leu967Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00135 (AC=2,180) in the gnomAD database across 1,613,804 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.0016. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (no review stars). ClinVar reports functional evidence for this variant: "SCV000603067: Functional assays suggest this variant has a modest or no effect on chloride channel activity, but exhibits decreased bicarbonate transport (LaRusch 2014, Raraigh 2018). PMID:25033378 PMID:29805046". Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.L967= (synonymous): Likely_benign (ClinVar VariationId 495916, 2 stars); p.L967= (synonymous): Likely_benign (ClinVar VariationId 2729011, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital bilateral aplasia of vas deferens from CFTR mutationInheritance: AR Classification: DEFINITIVE Submitted by: Natera
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Myriad Women's Health, ClinGen, Natera, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Uncertain_significance. The variant received 5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000603067: Functional assays suggest this variant has a modest or no effect on chloride channel activity, but exhibits decreased bicarbonate transport (LaRusch 2014, Raraigh 2018). PMID: 25033378 PMID: 29805046 | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CFTR | TSL:1MANE Select | c.2900T>C p.Leu967Ser | missense | Exon 17 of 27 | Prot: ENSP00000003084.6 UniProt: | |
CFTR | c.2900T>C p.Leu967Ser | missense | Exon 17 of 27 | Prot: ENSP00000514471.1 UniProt: | ||
CFTR | c.2813T>C p.Leu938Ser | missense | Exon 16 of 26 | Prot: ENSP00000559265.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00104 | AC:158 | Hom:0 | AN:152190 | Cov:33 |
GnomAD2 exomes | AF: 0.000721 | AC:181 | AN:251214 | ||
GnomAD4 exome | AF: 0.00138 | AC:2022 | Hom:1 | AN:1461496 | Cov:32 |
GnomAD4 genome | AF: 0.00104 | AC:158 | Hom:0 | AN:152308 | Cov:33 |
TOPMed (Bravo) | AF: 0.00104 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00121 | AC:603 | Hom:2 | AN:500378 | |
Local & regional cohorts 5 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.00214 | AC:5 | Hom:0 | AN:2342 | |
ESP6500 (Exome Variant Server) | AF: 0.000384 | AC:5 | AN:13006 | ||
GenomeAsia100K | AF: 0.000289 | AC:1 | AN:3478 | ||
Turkish Variome | AF: 0.000177 | AC:1 | Hom:0 | AN:5162 | |
UK10K | AF: 0.00145 | AC:11 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000900 * | 10 | 11112 | 0.000511 * | 9 | 17618 |
BipEx | 0.00144 | 41 | 28420 | 0.00159 | 46 | 28844 |
Epi25 | 0.00131 | 55 | 41956 | 0.00161 | 108 | 66878 |
SCHEMA | 0.000887 | 108 | 121732 | 0.000834 | 159 | 190620 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 23 | |
AlphaMissense | Benign | 0.23 | |
BayesDel_addAF | Uncertain | 0.014 | T |
BayesDel_noAF | Pathogenic | 0.24 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.46 | T |
Eigen | Uncertain | 0.35 | |
Eigen_PC | Uncertain | 0.32 | |
FATHMM_MKL | Uncertain | 0.94 | D |
FuncVEP CTI | Benign | 0.030 | |
GPN-Star LLR | N/A | -7.3 | |
GPN-Star score | N/A | 7.3 | |
LIST_S2 | Uncertain | 0.96 | D |
M_CAP | Uncertain | 0.26 | D |
MetaRNN | Benign | 0.14 | T |
MetaSVM | Uncertain | 0.45 | D |
Mutation Taster | N/A | 3/97 | disease causing (ClinVar) |
MutationAssessor | Benign | 1.3 | L |
PhyloP100 | Uncertain | 4.0 | |
popEVE | Benign | -2.9 | |
PrimateAI | Benign | 0.39 | T |
PROVEAN | Benign | 0.46 | N |
REVEL | Pathogenic | 0.66 | |
Sift | Uncertain | 0.0060 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.24 | |
VESM-3B | Benign | -9.8 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.